Target intelligence / Profile preview

Solute carrier family 9 member B1 pseudogene 2 (SLC9B1P2)

Target
SLC9B1P2
Molecular classification
Other (pseudogene, not a functional protein, receptor, enzyme, or transporter)
01

Overview

Solute carrier family 9 member B1 pseudogene 2 (SLC9B1P2, also known as NHEDC1P2), is a human pseudogene derived from the SLC9B1 gene, part of the Na+/H+ exchanger (NHE) family[1][3]. Unlike functional SLC9B1 or other NHE genes, SLC9B1P2 does not encode a functional protein or demonstrate transporter, receptor, or enzyme activity, and is not a therapeutic or diagnostic target. Its main relevance is genomic, as an annotated pseudogene found on chromosome 2p11.1[3]. There is no evidence of biological or pathophysiological function, clinical utility, drug interaction, or safety concerns related to SLC9B1P2. Key Points: - SLC9B1P2 is clearly designated a pseudogene in both nomenclature and gene databases[1][3]. - Pseudogenes are genomic sequences similar to known genes but do not produce functional proteins. - No evidence identifies SLC9B1P2 as a gene with protein products, receptor function, or involvement in cellular or disease pathways[1][3]. - It should not be considered a drug target or receptor, despite the overlapping nomenclature with functional SLC9B family members[1][3]. If a true, active Na+/H+ exchanger is the intended target (such as "solute carrier family 9 member B1" or SLC9B1/NHA1), please specify, as those are functional transporters and may be therapeutic targets[2][4][5].

Other names
NHEDC1P2Na+/H+ exchanger domain containing 1 pseudogene 2solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1 pseudogene 2solute carrier family 9, subfamily B (cation proton antiporter 2), member 1 pseudogene 2SLC9B1P2

Beyond the preview

Go deeper on Solute carrier family 9 member B1 pseudogene 2 (SLC9B1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 9 member B1 pseudogene 2 (SLC9B1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call